COMMUNIQUÉS West-GlobeNewswire

Nicox : Premières données d’une nouvelle classe prometteuse de donneurs d’oxyde nitrique (NO) pour le glaucome présentées au congrès ARVO 2019

03/05/2019 - 07:30

Communiqué de presse Nicox : Premières données d’une nouvelle classe prometteuse de donneurs d’oxyde nitrique (NO) pour le glaucome présentées au congrès ARVO 2019 Les donneurs d’oxyde nitrique (NO) inhibiteurs de la [...]

MDxHealth: Presentation of New Data for MDxHealth's Prostate Cancer Diagnostic Tests at AUA 2019 Annual Meeting

03/05/2019 - 07:01

PRESS RELEASE Moderated posters feature clinical validations of SelectMDx and ConfirmMDx IRVINE, CA, and HERSTAL, BELGIUM - MAY 3, 2019 - MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular [...]

MDxHealth (R) :

03/05/2019 - 07:01

Acacia Pharma Receives Complete Response Letter From Fda for Barhemsys®

03/05/2019 - 07:00

ACACIA PHARMA RECEIVES COMPLETE RESPONSE LETTER FROM FDA FOR BARHEMSYS ® This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and [...]

ObsEva SA Reports Consistent Long-Term Findings from Phase 2b EDELWEISS trial of Linzagolix for Endometriosis-Associated Pain

03/05/2019 - 07:00

Geneva, Switzerland and Boston, MA – May 3, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]

Tetra Bio-Pharma’s Subsidiary, Panag Pharma, Obtains Health Canada Authorization to Commence Its First Veterinary Clinical Study

03/05/2019 - 01:30

Commences Path Towards Approval in Lucrative Companion Animal Market OTTAWA, May 02, 2019 (GLOBE NEWSWIRE) -- Panag Pharma Inc. (Panag), a subsidiary of Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP [...]

Guardant Health to Report First Quarter 2019 Financial Results on May 9, 2019

03/05/2019 - 00:21

REDWOOD CITY, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the first quarter 2019 after market close on Thursday, May 9, 2019. Company [...]

RadNet, Inc. Announces Date of its First Quarter 2019 Financial Results Conference Call

03/05/2019 - 00:15

LOS ANGELES, May 02, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]

Avricore Health Announces Late Filing of Annual Financial Statements and Management Cease Trade Order

02/05/2019 - 23:22

Vancouver, May 02, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore Health” or the “Company”) announced today that as a result of delays in completion of its audit, the Company did not file its [...]

Resverlogix Announces 3-Month Loan Extension

02/05/2019 - 23:12

CALGARY, Alberta, May 02, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX) today announces that it has entered into an amending agreement with Third Eye Capital (acting as agent for [...]

European Medicines Agency Recommends Orphan Drug Designation for Relacorilant to Treat Patients with Cushing’s Syndrome

02/05/2019 - 23:05

MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]

Osmotica Pharmaceuticals plc to Provide First Quarter 2019 Business and Financial Update on May 9, 2019

02/05/2019 - 23:00

BRIDGEWATER, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that the Company will release [...]

R1 to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

02/05/2019 - 23:00

CHICAGO, May 02, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced its management team will present [...]

Dynavax Announces First Patient Enrolled in Study of HEPLISAV-B® [Hepatitis B Vaccine, Recombinant (Adjuvanted)] in Adults With End-Stage Renal Disease

02/05/2019 - 23:00

Trial to evaluate immunogenicity and safety of Hepatitis B vaccine, HEPLISAV-B, in patients with end-stage renal disease who are initiating or undergoing dialysis BERKELEY, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- [...]

Coherus BioSciences and Amgen Settle Trade Secrets Action

02/05/2019 - 23:00

Coherus Continues to Commercialize UDENYCA® Across All Segments REDWOOD CITY, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that Amgen and Coherus have [...]

Novartis to highlight extensive long-term safety and efficacy data of Aimovig® across the spectrum of migraine at AAN

02/05/2019 - 22:31

After long-term Aimovig (erenumab) treatment, two-thirds of chronic migraine patients converted to episodic migraine, experiencing 11 fewer migraine days per month on average Separate study showed the majority of [...]

Rockwell Medical, Inc. to Discuss First Quarter 2019 Financial Results on May 9, 2019

02/05/2019 - 22:30

WIXOM, Mich., May 02, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 first quarter financial results on [...]

Idera Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update

02/05/2019 - 22:30

EXTON, Pa., May 02, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately the commercialization, of [...]

Melinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019

02/05/2019 - 22:30

MORRISTOWN, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]